Epigenetic differences in monozygotic twins discordant for major depressive disorder

Malki, K., Koritskaya, E., Harris, F., Bryson, K. , Herbster, M. and Tosto, M.G. (2016) Epigenetic differences in monozygotic twins discordant for major depressive disorder. Translational Psychiatry, 6, e839. (doi: 10.1038/tp.2016.101) (PMID:27300265) (PMCID:PMC4931599)

Abstract

Although monozygotic (MZ) twins share the majority of their genetic makeup, they can be phenotypically discordant on several traits and diseases. DNA methylation is an epigenetic mechanism that can be influenced by genetic, environmental and stochastic events and may have an important impact on individual variability. In this study we explored epigenetic differences in peripheral blood samples in three MZ twin studies on major depressive disorder (MDD). Epigenetic data for twin pairs were collected as part of a previous study using 8.1-K-CpG microarrays tagging DNA modification in white blood cells from MZ twins discordant for MDD. Data originated from three geographical regions: UK, Australia and the Netherlands. Ninety-seven MZ pairs (194 individuals) discordant for MDD were included. Different methods to address non independently-and-identically distributed (non-i.i.d.) data were evaluated. Machine-learning methods with feature selection centered on support vector machine and random forest were used to build a classifier to predict cases and controls based on epivariations. The most informative variants were mapped to genes and carried forward for network analysis. A mixture approach using principal component analysis (PCA) and Bayes methods allowed to combine the three studies and to leverage the increased predictive power provided by the larger sample. A machine-learning algorithm with feature reduction classified affected from non-affected twins above chance levels in an independent training-testing design. Network analysis revealed gene networks centered on the PPAR−γ (NR1C3) and C-MYC gene hubs interacting through the AP-1 (c-Jun) transcription factor. PPAR−γ (NR1C3) is a drug target for pioglitazone, which has been shown to reduce depression symptoms in patients with MDD. Using a data-driven approach we were able to overcome challenges of non-i.i.d. data when combining epigenetic studies from MZ twins discordant for MDD. Individually, the studies yielded negative results but when combined classification of the disease state from blood epigenome alone was possible. Network analysis revealed genes and gene networks that support the inflammation hypothesis of MDD.

• Item Type: Articles
• Additional Information: Dr Malki is supported by an MRC grant (G9817803).
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Bryson, Dr Kevin
• Authors: Malki, K., Koritskaya, E., Harris, F., Bryson, K., Herbster, M., and Tosto, M.G.
• College/School: College of Science and Engineering > School of Computing Science
• Journal Name: Translational Psychiatry
• Publisher: Springer Nature
• ISSN: 2158-3188
• ISSN (Online): 2158-3188
• Published Online: 14 June 2016
• Copyright Holders: Copyright: © The Author(s) 2016
• First Published: First published in Translational Psychiatry 6: e839
• Publisher Policy: Reproduced under a Creative Commons licence